Abstract

This study aims to identify and isolate the secondary metabolites of Zingiber officinale using GC-MS, preparative TLC, and LC-MS/MS methods, to evaluate the inhibitory potency on SARS-CoV-2 3 chymotrypsin-like protease enzyme, as well as to study the molecular interaction and stability by using docking and molecular dynamics simulations. GC-MS analysis suggested for the isolation of terpenoids compounds as major compounds on methanol extract of pseudostems and rhizomes. Isolation and LC-MS/MS analysis identified 5-hydro-7, 8, 2′-trimethoxyflavanone (9), (E)-hexadecyl-ferulate (1), isocyperol (2), N-isobutyl-(2E,4E)-octadecadienamide (3), and nootkatone (4) from the rhizome extract, as well as from the leaves extract with the absence of 9. Three known steroid compounds, i.e., spinasterone (7), spinasterol (8), and 24-methylcholesta-7-en-3β-on (6), were further identified from the pseudostem extract. Molecular docking showed that steroids compounds 7, 8, and 6 have lower predictive binding energies (MMGBSA) than other metabolites with binding energy of −87.91, −78.11, and −68.80 kcal/mole, respectively. Further characterization on the single isolated compound by NMR showed that 6 was identified and possessed 75% inhibitory activity on SARS-CoV-2 3CL protease enzyme that was slightly different with the positive control GC376 (77%). MD simulations showed the complex stability with compound 6 during 100 ns simulation time.

Highlights

  • COVID-19, caused by the SARS-CoV-2 virus, is a global pandemic that has negatively impacted human life in this recent time

  • 3 Chymotrypsin-like protease (3CLpro) SARS-CoV-2 has become an interesting target, as if it is inhibited, the viral replication process will be disrupted by inhibiting the viral polyproteins cleavage [4]

  • The docking molecular study of its main metabolites on 3 chymotrypsin-like protease SARS-CoV-2 receptor suggested their potency as antivirus for treating COVID-19 [18]

Read more

Summary

Introduction

COVID-19, caused by the SARS-CoV-2 virus, is a global pandemic that has negatively impacted human life in this recent time. 3 Chymotrypsin-like protease (3CLpro) SARS-CoV-2 has become an interesting target, as if it is inhibited, the viral replication process will be disrupted by inhibiting the viral polyproteins cleavage [4]. Respiratory disorders, diabetes mellitus, obesity, cardiovascular, and neurodegenerative defects were reported among diseases that can be treated using ginger [11,12,13,14,15]. These activities were reported to possess the such effects due to the content of phenolic compounds, such as gingerols, shogaols, and paradols. The docking molecular study of its main metabolites on 3 chymotrypsin-like protease SARS-CoV-2 receptor suggested their potency as antivirus for treating COVID-19 [18]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.